Skip to main content
Erschienen in: Journal of Neurology 6/2009

01.06.2009 | Original Communication

Intracortical excitability in patients with relapsing–remitting and secondary progressive multiple sclerosis

verfasst von: A. Conte, D. Lenzi, V. Frasca, F. Gilio, E. Giacomelli, M. Gabriele, C. Marini Bettolo, E. Iacovelli, P. Pantano, C. Pozzilli, M. Inghilleri

Erschienen in: Journal of Neurology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

We designed this study to investigate possible correlations between variables measuring primary motor cortex excitability detected by single and paired-pulse transcranial magnetic stimulation (TMS) and the severity of clinical manifestations in patients with multiple sclerosis (MS). Thirty patients with MS in remission, 16 with relapsing–remitting (RR), 14 with secondary progressive disease (SP) and 17 healthy subjects participated in the study. In each subject, the central motor conduction time (CMCT) was calculated, and single-pulse and paired-pulse TMS at 3 and 10 ms interstimulus intervals was delivered over the primary motor cortex of the dominant hemisphere to measure the amplitude of motor-evoked potentials (MEPs), motor threshold (MTh), intracortical inhibition (ICI) and facilitation (ICF). Correlations were determined between the patients’ TMS findings and magnetic resonance imaging (MRI) (lesion load) and clinical features (expanded disability status scale, EDSS score). EDSS scores were significantly higher in SPMS than in RRMS patients. The MTh was significantly higher, and the MEP was significantly smaller in SPMS patients than in RRMS patients and control subjects. All patients had longer CMCTs than healthy subjects. In all patients, paired-pulse TMS elicited an inhibited test MEP at the 3-ms ISI and a facilitated test MEP at the 10 ms ISI. Post hoc analysis showed that ICI was significantly lower in SPMS patients than in those with RRMS and healthy subjects. EDSS scores correlated significantly with TMS measures (MEP, ICI, CMCT and MTh), but not with MRI lesion load. It was found that intracortical excitability as measured with TMS differs according to the clinical course of MS; it remains normal in patients with low EDSS scores and is altered in patients with high EDSS scores.
Literatur
1.
Zurück zum Zitat Berardelli A, Inghilleri M, Cruccu G, Fornarelli M, Accornero N, Manfredi M (1988) Stimulation of motor tract in multiple sclerosis. J Neurol Neurosurg Psychiatry 51:677–683PubMedCrossRef Berardelli A, Inghilleri M, Cruccu G, Fornarelli M, Accornero N, Manfredi M (1988) Stimulation of motor tract in multiple sclerosis. J Neurol Neurosurg Psychiatry 51:677–683PubMedCrossRef
2.
Zurück zum Zitat Boniface SJ (2001) Plasticity after acute ischaemic stroke studied by transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry 71:713–715PubMedCrossRef Boniface SJ (2001) Plasticity after acute ischaemic stroke studied by transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry 71:713–715PubMedCrossRef
3.
Zurück zum Zitat Calabrese M, Atzori M, Bernardi V et al (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254:1212–1220PubMedCrossRef Calabrese M, Atzori M, Bernardi V et al (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254:1212–1220PubMedCrossRef
4.
Zurück zum Zitat Ciccarelli O, Brex PA, Thompson AJ, Miller DH (2002) Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J Neurol 249:18–24PubMedCrossRef Ciccarelli O, Brex PA, Thompson AJ, Miller DH (2002) Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J Neurol 249:18–24PubMedCrossRef
5.
Zurück zum Zitat Caramia MD, Palmieri MG, Desiato MT et al (2004) Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clin Neurophysiol 15:956–965CrossRef Caramia MD, Palmieri MG, Desiato MT et al (2004) Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clin Neurophysiol 15:956–965CrossRef
6.
Zurück zum Zitat Classen J, Schnitzler A, Binkofski F et al (1997) The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic stroke. Brain 120:605–619PubMedCrossRef Classen J, Schnitzler A, Binkofski F et al (1997) The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic stroke. Brain 120:605–619PubMedCrossRef
7.
Zurück zum Zitat Curra A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A (2002) Transcranial magnetic stimulation techniques in clinical investigation. Neurology 59:1851–1859PubMed Curra A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A (2002) Transcranial magnetic stimulation techniques in clinical investigation. Neurology 59:1851–1859PubMed
8.
Zurück zum Zitat Dehmeshki J, Chard DT, Leary SM et al (2003) The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 250:67–74PubMedCrossRef Dehmeshki J, Chard DT, Leary SM et al (2003) The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 250:67–74PubMedCrossRef
9.
Zurück zum Zitat Facchetti D, Mai R, Micheli A et al (1997) Motor evoked potentials and disability in secondary progressive multiple sclerosis. Can J Neurol Sci 24:332–337PubMed Facchetti D, Mai R, Micheli A et al (1997) Motor evoked potentials and disability in secondary progressive multiple sclerosis. Can J Neurol Sci 24:332–337PubMed
10.
Zurück zum Zitat Fierro B, Salemi G, Brighina F et al (2002) A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand 105:152–157PubMedCrossRef Fierro B, Salemi G, Brighina F et al (2002) A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand 105:152–157PubMedCrossRef
11.
Zurück zum Zitat Fuhr P, Kappos L (2001) Evoked potentials for evaluation of multiple sclerosis. Clin Neurophysiol 112:2185–2189PubMedCrossRef Fuhr P, Kappos L (2001) Evoked potentials for evaluation of multiple sclerosis. Clin Neurophysiol 112:2185–2189PubMedCrossRef
12.
Zurück zum Zitat Geurts GJ, Barkhof F (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7:841–851PubMedCrossRef Geurts GJ, Barkhof F (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7:841–851PubMedCrossRef
13.
Zurück zum Zitat Grimaud J, Lai M, Thorpe J et al (1996) Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 14:495–505PubMedCrossRef Grimaud J, Lai M, Thorpe J et al (1996) Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 14:495–505PubMedCrossRef
14.
Zurück zum Zitat Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A (2004) Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the expanded disability status scale and multiple sclerosis functional composite. Mult Scler 10:41–46PubMedCrossRef Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A (2004) Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the expanded disability status scale and multiple sclerosis functional composite. Mult Scler 10:41–46PubMedCrossRef
15.
Zurück zum Zitat Humm AM, Truffert A, Magistris MR, Rösler KM (2002) Central motor conduction in acute relapsing–remitting versus chronic progressive multiple sclerosis. J Neurol 249:I/101–I/102 Humm AM, Truffert A, Magistris MR, Rösler KM (2002) Central motor conduction in acute relapsing–remitting versus chronic progressive multiple sclerosis. J Neurol 249:I/101–I/102
16.
Zurück zum Zitat Humm AM, Magistris MR, Truffert A, Hess CW, Rösler KM (2003) Central motor conduction differs between acute relapsing–remitting and chronic progressive multiple sclerosis. Clin Neurophysiol 114:2196–2203PubMedCrossRef Humm AM, Magistris MR, Truffert A, Hess CW, Rösler KM (2003) Central motor conduction differs between acute relapsing–remitting and chronic progressive multiple sclerosis. Clin Neurophysiol 114:2196–2203PubMedCrossRef
17.
Zurück zum Zitat Humm AM, Z’Graggen WJ, Bühler R, Magistris MR, Rösler KM (2006) Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone. J Neurol Neurosurg Psychiatry 77:345–350PubMedCrossRef Humm AM, Z’Graggen WJ, Bühler R, Magistris MR, Rösler KM (2006) Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone. J Neurol Neurosurg Psychiatry 77:345–350PubMedCrossRef
18.
Zurück zum Zitat Kandler RH, Jarratt JA, Davies-Jones GA et al (1991) The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J Neurol Sci 106:31–34PubMedCrossRef Kandler RH, Jarratt JA, Davies-Jones GA et al (1991) The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis. J Neurol Sci 106:31–34PubMedCrossRef
19.
Zurück zum Zitat Khaleeli Z, Cercignani M, Audoin B et al (2007) Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 37:253–261PubMedCrossRef Khaleeli Z, Cercignani M, Audoin B et al (2007) Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 37:253–261PubMedCrossRef
20.
Zurück zum Zitat Kidd D, Thompson PD, Day BL et al (1998) Central motor conduction time in progressive multiple sclerosis. Correlations with MRI and disease activity. Brain 121:1109–1116PubMedCrossRef Kidd D, Thompson PD, Day BL et al (1998) Central motor conduction time in progressive multiple sclerosis. Correlations with MRI and disease activity. Brain 121:1109–1116PubMedCrossRef
21.
Zurück zum Zitat Kujirai T, Caramia MD, Rothwell JC et al (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519PubMed Kujirai T, Caramia MD, Rothwell JC et al (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519PubMed
22.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed
23.
Zurück zum Zitat Liepert J, Mingers D, Heesen C, Baumer T, Weiller C (2005) Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler 11:316–321PubMedCrossRef Liepert J, Mingers D, Heesen C, Baumer T, Weiller C (2005) Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study. Mult Scler 11:316–321PubMedCrossRef
24.
Zurück zum Zitat Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907–911PubMed Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907–911PubMed
25.
Zurück zum Zitat Mainero C, Inghilleri M, Pantano P et al (2004) Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine. Neurology 62:2044–2050PubMed Mainero C, Inghilleri M, Pantano P et al (2004) Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine. Neurology 62:2044–2050PubMed
26.
Zurück zum Zitat Masek M, Vaneckova M, Krasensky J et al (2008) Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. Neuro Endocrinol Lett 29:461–466PubMed Masek M, Vaneckova M, Krasensky J et al (2008) Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. Neuro Endocrinol Lett 29:461–466PubMed
27.
Zurück zum Zitat Oreja-Guevara C, Charil A, Caputo D et al (2006) Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis. Arch Neurol 63:736–740PubMedCrossRef Oreja-Guevara C, Charil A, Caputo D et al (2006) Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis. Arch Neurol 63:736–740PubMedCrossRef
28.
Zurück zum Zitat Rovaris M, Judica E, Gallo A et al (2006) Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 129:2628–2634PubMedCrossRef Rovaris M, Judica E, Gallo A et al (2006) Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 129:2628–2634PubMedCrossRef
29.
Zurück zum Zitat Schmierer K, Irlbacher K, Grosse P, Röricht S, Meyer BU (2002) Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation. Neurology 59:1218–1224PubMed Schmierer K, Irlbacher K, Grosse P, Röricht S, Meyer BU (2002) Correlates of disability in multiple sclerosis detected by transcranial magnetic stimulation. Neurology 59:1218–1224PubMed
30.
Zurück zum Zitat Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120:299–315PubMedCrossRef Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120:299–315PubMedCrossRef
31.
Zurück zum Zitat Talairach J, Tournoux P (1988) Coplanar stereotaxic atlas of the human brain. Thieme, Stuttgart Talairach J, Tournoux P (1988) Coplanar stereotaxic atlas of the human brain. Thieme, Stuttgart
32.
Zurück zum Zitat Tassinari CA, Cincotta M, Zaccara G, Michelacci R (2003) Transcranial magnetic stimulation and epilepsy. Clin Neurophysiol 114:777–798PubMedCrossRef Tassinari CA, Cincotta M, Zaccara G, Michelacci R (2003) Transcranial magnetic stimulation and epilepsy. Clin Neurophysiol 114:777–798PubMedCrossRef
33.
Zurück zum Zitat Vrenken H, Pouwels PJ, Geurts JJ et al (2006) Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 23:628–636PubMedCrossRef Vrenken H, Pouwels PJ, Geurts JJ et al (2006) Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 23:628–636PubMedCrossRef
Metadaten
Titel
Intracortical excitability in patients with relapsing–remitting and secondary progressive multiple sclerosis
verfasst von
A. Conte
D. Lenzi
V. Frasca
F. Gilio
E. Giacomelli
M. Gabriele
C. Marini Bettolo
E. Iacovelli
P. Pantano
C. Pozzilli
M. Inghilleri
Publikationsdatum
01.06.2009
Verlag
D. Steinkopff-Verlag
Erschienen in
Journal of Neurology / Ausgabe 6/2009
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5047-0

Weitere Artikel der Ausgabe 6/2009

Journal of Neurology 6/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.